We previously developed the PDX version 2 (PDXv2) model, where melanoma tumours were grown in immunocompromised non-obese diabetic severe combined immunodeficiency interleukin 2 receptor gamma knockout mice (NSG/NOG) transgenic for human interleukin 2 (hIL2-NOG) [13]. This evidence concerns the gene IL2 and neoplasm.